CTP of β-hCG Vaccine
Carboxy Terminus Peptide of β-Human Chorionic Gonadotropin
- User: Female
- Hormonal: Non-Hormonal
-
Delivery type:
- Not Yet Determined
-
Intended Duration:
- Not Yet Determined
- Development Stage: Phase II
- Developer(s)/researcher(s): Talwar Research Foundation, Indian Council for Medical Research
Details
- API: CTP of β-hCG
- Target: hCG
-
Mechanism of Action:
- Other
- MPT: Not Potential MPT
- Promising Attributes: Developer believes the product would have few, if any, side effects while having the benefits of other injectables - discretion, ease of use, affordability.
Product Status
Recent Media Interviews Regarding Development
History
Evaluated, predominantly by Talwar Research Foundation, beginning as early as 1975. While recent public results are limited, lead developers continue to promote the approach and discuss lab work.